Literature DB >> 22505458

The dendritic cell receptor DNGR-1 controls endocytic handling of necrotic cell antigens to favor cross-priming of CTLs in virus-infected mice.

Santiago Zelenay1, Anna M Keller, Paul G Whitney, Barbara U Schraml, Safia Deddouche, Neil C Rogers, Oliver Schulz, David Sancho, Caetano Reis e Sousa.   

Abstract

DNGR-1 (CLEC9A) is a receptor for necrotic cells required by DCs to cross-prime CTLs against dead cell antigens in mice. It is currently unknown how DNGR-1 couples dead cell recognition to cross-priming. Here we found that DNGR-1 did not mediate DC activation by dead cells but rather diverted necrotic cell cargo into a recycling endosomal compartment, favoring cross-presentation to CD8(+) T cells. DNGR-1 regulated cross-priming in non-infectious settings such as immunization with antigen-bearing dead cells, as well as in highly immunogenic situations such as infection with herpes simplex virus type 1. Together, these results suggest that DNGR-1 is a dedicated receptor for cross-presentation of cell-associated antigens. Our work thus underscores the importance of cross-priming in immunity and indicates that antigenicity and adjuvanticity can be decoded by distinct innate immune receptors. The identification of specialized receptors that regulate antigenicity of virus-infected cells reveals determinants of antiviral immunity that might underlie the human response to infection and vaccination.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22505458      PMCID: PMC3336984          DOI: 10.1172/JCI60644

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  74 in total

1.  Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity.

Authors:  Olaf Gross; Andreas Gewies; Katrin Finger; Martin Schäfer; Tim Sparwasser; Christian Peschel; Irmgard Förster; Jürgen Ruland
Journal:  Nature       Date:  2006-07-12       Impact factor: 49.962

2.  Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming.

Authors:  Rhys S Allan; Jason Waithman; Sammy Bedoui; Claerwen M Jones; Jose A Villadangos; Yifan Zhan; Andrew M Lew; Ken Shortman; William R Heath; Francis R Carbone
Journal:  Immunity       Date:  2006-07       Impact factor: 31.745

3.  Differential antigen processing by dendritic cell subsets in vivo.

Authors:  Diana Dudziak; Alice O Kamphorst; Gordon F Heidkamp; Veit R Buchholz; Christine Trumpfheller; Sayuri Yamazaki; Cheolho Cheong; Kang Liu; Han-Woong Lee; Chae Gyu Park; Ralph M Steinman; Michel C Nussenzweig
Journal:  Science       Date:  2007-01-05       Impact factor: 47.728

4.  Apoptotic cells induce tolerance by generating helpless CD8+ T cells that produce TRAIL.

Authors:  Thomas S Griffith; Hirotaka Kazama; Rebecca L VanOosten; James K Earle; John M Herndon; Douglas R Green; Thomas A Ferguson
Journal:  J Immunol       Date:  2007-03-01       Impact factor: 5.422

Review 5.  Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo.

Authors:  José A Villadangos; Petra Schnorrer
Journal:  Nat Rev Immunol       Date:  2007-07       Impact factor: 53.106

6.  Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation.

Authors:  Sven Burgdorf; Andreas Kautz; Volker Böhnert; Percy A Knolle; Christian Kurts
Journal:  Science       Date:  2007-04-27       Impact factor: 47.728

7.  Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17.

Authors:  Salomé LeibundGut-Landmann; Olaf Gross; Matthew J Robinson; Fabiola Osorio; Emma C Slack; S Vicky Tsoni; Edina Schweighoffer; Victor Tybulewicz; Gordon D Brown; Jürgen Ruland; Caetano Reis e Sousa
Journal:  Nat Immunol       Date:  2007-04-22       Impact factor: 25.606

8.  Rab27a regulates phagosomal pH and NADPH oxidase recruitment to dendritic cell phagosomes.

Authors:  Carolina Jancic; Ariel Savina; Christina Wasmeier; Tanya Tolmachova; Jamel El-Benna; Pham My-Chan Dang; Steve Pascolo; Maire-Anne Gougerot-Pocidalo; Graça Raposo; Miguel C Seabra; Sebastian Amigorena
Journal:  Nat Cell Biol       Date:  2007-03-11       Impact factor: 28.824

9.  The C-type lectin receptors CLEC-2 and Dectin-1, but not DC-SIGN, signal via a novel YXXL-dependent signaling cascade.

Authors:  Gemma L J Fuller; Jennifer A E Williams; Michael G Tomlinson; Johannes A Eble; Sheri L Hanna; Stefan Pöhlmann; Katsue Suzuki-Inoue; Yukio Ozaki; Steve P Watson; Andrew C Pearce
Journal:  J Biol Chem       Date:  2007-03-05       Impact factor: 5.157

10.  Enhancing immunogenicity by limiting susceptibility to lysosomal proteolysis.

Authors:  Lélia Delamarre; Rachael Couture; Ira Mellman; E Sergio Trombetta
Journal:  J Exp Med       Date:  2006-08-14       Impact factor: 14.307

View more
  115 in total

1.  Dendritic cells: actin a dangerous part.

Authors:  Yvonne Bordon
Journal:  Nat Rev Immunol       Date:  2012-04-25       Impact factor: 53.106

2.  Immunology: Actin' dangerously.

Authors:  Gordon D Brown
Journal:  Nature       Date:  2012-05-31       Impact factor: 49.962

Review 3.  Sizing up the key determinants of the CD8(+) T cell response.

Authors:  David C Tscharke; Nathan P Croft; Peter C Doherty; Nicole L La Gruta
Journal:  Nat Rev Immunol       Date:  2015-10-09       Impact factor: 53.106

4.  RNF41 regulates the damage recognition receptor Clec9A and antigen cross-presentation in mouse dendritic cells.

Authors:  Kirsteen M Tullett; Peck Szee Tan; Hae-Young Park; Ralf B Schittenhelm; Nicole Michael; Rong Li; Antonia N Policheni; Emily Gruber; Cheng Huang; Alex J Fulcher; Jillian C Danne; Peter E Czabotar; Linda M Wakim; Justine D Mintern; Georg Ramm; Kristen J Radford; Irina Caminschi; Meredith O'Keeffe; Jose A Villadangos; Mark D Wright; Marnie E Blewitt; William R Heath; Ken Shortman; Anthony W Purcell; Nicos A Nicola; Jian-Guo Zhang; Mireille H Lahoud
Journal:  Elife       Date:  2020-12-02       Impact factor: 8.140

5.  IL17A Regulates Tumor Latency and Metastasis in Lung Adeno and Squamous SQ.2b and AD.1 Cancer.

Authors:  Ran You; Francesco J DeMayo; Jian Liu; Sung-Nam Cho; Bryan M Burt; Chad J Creighton; Roberto F Casal; Donald R Lazarus; Wen Lu; Hui-Ying Tung; Xiaoyi Yuan; Andrea Hill-McAlester; Myunghoo Kim; Sarah Perusich; Loraine Cornwell; Daniel Rosen; Li-Zhen Song; Silke Paust; Gretchen Diehl; David Corry; Farrah Kheradmand
Journal:  Cancer Immunol Res       Date:  2018-04-13       Impact factor: 11.151

Review 6.  Inflammasomes and adaptive immune responses.

Authors:  Katherine A Deets; Russell E Vance
Journal:  Nat Immunol       Date:  2021-02-18       Impact factor: 25.606

Review 7.  Innate and adaptive immune cells in the tumor microenvironment.

Authors:  Thomas F Gajewski; Hans Schreiber; Yang-Xin Fu
Journal:  Nat Immunol       Date:  2013-10       Impact factor: 25.606

8.  Targeting CLEC9A delivers antigen to human CD141+ DC for CD4+ and CD8+T cell recognition.

Authors:  Kirsteen M Tullett; Ingrid M Leal Rojas; Yoshihito Minoda; Peck S Tan; Jian-Guo Zhang; Corey Smith; Rajiv Khanna; Ken Shortman; Irina Caminschi; Mireille H Lahoud; Kristen J Radford
Journal:  JCI Insight       Date:  2016-05-19

Review 9.  Molecular regulation of dendritic cell development and function in homeostasis, inflammation, and cancer.

Authors:  Taylor T Chrisikos; Yifan Zhou; Natalie Slone; Rachel Babcock; Stephanie S Watowich; Haiyan S Li
Journal:  Mol Immunol       Date:  2018-03-15       Impact factor: 4.407

10.  Display of Native Antigen on cDC1 That Have Spatial Access to Both T and B Cells Underlies Efficient Humoral Vaccination.

Authors:  Yu Kato; Thiago M Steiner; Hae-Young Park; Rohan O Hitchcock; Ali Zaid; Jyh Liang Hor; Sapna Devi; Gayle M Davey; David Vremec; Kirsteen M Tullett; Peck S Tan; Fatma Ahmet; Scott N Mueller; Sylvie Alonso; David M Tarlinton; Hidde L Ploegh; Tsuneyasu Kaisho; Lynette Beattie; Jonathan H Manton; Daniel Fernandez-Ruiz; Ken Shortman; Mireille H Lahoud; William R Heath; Irina Caminschi
Journal:  J Immunol       Date:  2020-08-24       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.